07/11/2025
4:13 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2025
7:04 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
3:53 PM | BAKER JULIAN (Reporting)
Denali Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/05/2025
3:57 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Denali Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/05/2025
3:23 PM | Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:25 PM | Denali Therapeutics (Issuer)
Thornberry Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:26 PM | Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
3:05 PM | Denali Therapeutics (Filer)
| Form DEF 14A | |
04/17/2025
3:06 PM | Denali Therapeutics (Filer)
| Form DEFA14A | |
04/17/2025
3:07 PM | Denali Therapeutics (Filer)
| Form ARS | |
04/17/2025
2:05 PM | BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for DNLI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Denali Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/02/2025
7:02 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
4:26 PM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
3:11 PM | Denali Therapeutics (Filer)
| Form S-3ASR | |
02/27/2025
3:12 PM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
3:13 PM | Denali Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/13/2025
1:14 PM | Capital Research Global Investors (Filed by)
Denali Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
9:52 AM | BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
7:03 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:23 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:24 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:25 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:26 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:01 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:03 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:06 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:08 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:10 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:12 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:14 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
5:56 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:57 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:59 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:17 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/31/2024
3:18 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:44 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
4:19 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
8:55 AM | Denali Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Denali Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
3:39 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:30 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Critical AI announcement set to ignite AI 2.0 (Ad) I just put together an urgent new presentation that you need to see right away.
In short: I believe we are mere days away from a critical announcement from a key tech leader…
One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.  Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
| Form SC 13G/A | |
10/18/2024
3:19 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
3:37 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:25 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:25 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
5:26 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:14 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:14 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:15 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:16 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
3:40 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:42 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:08 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:08 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:09 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:09 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:27 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
12:18 PM | Denali Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
08/15/2024
3:10 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
7:36 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
7:37 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
5:52 AM | Denali Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
5:48 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free DNLI Stock Alerts